Search research articles
Contact Us
Filters
Showing results (131-140 of 136) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 136 results.
Eclinicalmedicine
|
July 29, 2025
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial
Alexander Rumyantsev, Lixia Wang, Shixia Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2023
Characterization and Investigation of Risk Factors for Late-Relapsing Hepatitis After Yellow Fever
Izabela Mauricio de Rezende, Max A McClure, Leonardo S Pereira, et al.
Frontiers in Medicine
|
February 11, 2025
Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil
Max McClure, Izabela Maurício de Rezende, Leonardo Soares Pereira, et al.
Emerging Microbes & Infections
|
October 26, 2022
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2
Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, et al.
The New England Journal of Medicine
|
April 2, 2015
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
Jason A Regules, John H Beigel, Kristopher M Paolino, et al.
The Journal of Clinical Investigation
|
March 22, 2022
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants
Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 136) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 136 results.
Eclinicalmedicine
|
July 29, 2025
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial
Alexander Rumyantsev, Lixia Wang, Shixia Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2023
Characterization and Investigation of Risk Factors for Late-Relapsing Hepatitis After Yellow Fever
Izabela Mauricio de Rezende, Max A McClure, Leonardo S Pereira, et al.
Frontiers in Medicine
|
February 11, 2025
Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil
Max McClure, Izabela Maurício de Rezende, Leonardo Soares Pereira, et al.
Emerging Microbes & Infections
|
October 26, 2022
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2
Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, et al.
The New England Journal of Medicine
|
April 2, 2015
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
Jason A Regules, John H Beigel, Kristopher M Paolino, et al.
The Journal of Clinical Investigation
|
March 22, 2022
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants
Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, et al.
Page
of 14